All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

›ETF Issuers›Global X›HMMJ

HMMJ

Global X Marijuana Life Sciences Index ETF

Passive ETF Equity Theme: Cannabis & Psychedelics

The HMMJ Exchange Traded Fund (ETF) is provided by Global X. It is built to track an index: North American Marijuana Index. The HMMJ ETF provides physical exposure, so by buying it you actually own parts of all the 14 underlying holdings. This share class generates a stream of income by distributing dividends.

$7.05

-$0.02 (-0.28%) yesterday

1:30 PM 07/16/26 Closed

1D price range

$7.00$7.10

52W price range

$6.80$10.19

YTD Perf.

-7.93%

YTD Flows

Annualized volatility

Fund AuM

€26M

Share class AuM

€26M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

CA37991D1042

TER

Inception date

6/16/2017

Issuer

Global X

Benchmark

North American Marijuana Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

No content available for this fund

API

PerformanceDec 31, 2025 - Jul 16, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 05/31/26

Consumer Non-Cyclicals

42.39%

Finance

18.51%

Healthcare

16.31%

Consumer Cyclicals

8.17%

Non-Energy Materials

4.47%

Unavailable

10.15%

Latest HMMJ news

No content available for this fund

FAQ about HMMJ

HMMJ is a Passive ETF. This ETF provides exposure to North American Equities.

HMMJ tracks the North American Marijuana Total Return Index - CAD, through a full replication replication method.

HMMJ carries a total expense ratio (TER) of 1%, indicating the annual cost for holding the fund.

HMMJ was introduced to the market on June 16, 2017. It trades on Canada

Global X Marijuana Life Sciences Index ETF, HMMJ, is provided by Global X. Learn more about Global X here.

HMMJ oversees €26M in assets as of July 16, 2026.

HMMJ follows a distributing dividend policy, meaning it pays out income to investors. As of July 16, 2026, its 12-month trailing yield was 1.44%.

As of May 31, 2026, HMMJ has significant geographic allocations in Canada, USA and Ireland.

As of May 31, 2026, HMMJ focuses largely on Consumer Non-Cyclicals, Finance and Healthcare.

As of May 31, 2026, HMMJ holds 14 positions in its portfolio, with 89.85% of assets concentrated in its top 15 holdings.

As of May 31, 2026, HMMJ top three holdings include Jazz Pharmaceuticals Plc, Cronos Group, Inc. and Innovative Industrial Properties, Inc..

The base currency of HMMJ is CAD.

Top 10 holdings

Data as of 05/31/26

Jazz Pharmaceuticals Plc

12.35%

Cronos Group, Inc.

11.15%

Innovative Industrial Properties, Inc.

10.59%

SNDL, Inc.

10.34%

Canopy Growth Corp.

9.90%

High Tide, Inc.

5.73%

Chicago Atlantic BDC, Inc.

5.68%

Aurora Cannabis, Inc.

5.32%

Scotts Miracle-Gro Co.

4.47%

Corbus Pharmaceuticals Holdings, Inc.

3.96%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Don’t Miss a Move in the ETF Market

Global X Marijuana Life Sciences Index ETF

FAQ about HMMJ

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US